A key feature of EMT in HCC is the disruption of E-cadherin/β-catenin complexes at cell boundaries, accompanied by nuclear translocation of β-catenin, which ultimately promotes EMT and resistance to sorafenib. The gene discussed is CDH1; the disease is hepatocellular carcinoma.